Subu Nambi
Analyst
Guggenheim Securities
Equibles does not estimate personal net worth.
About Subu Nambi
Subu Nambi is recorded as Analyst at Guggenheim Securities. Subu Nambi has spoken on 3 earnings calls across 2 companies, most recently for 10x Genomics, Inc. on February 12, 2026. Those appearances were for 10x Genomics, Inc. (TXG) and Repligen Corp (RGEN). The companies whose calls Subu Nambi spoke on are classified in the Healthcare sector.
Subu Nambi on recent calls
“Looking ahead to AGBT, how are you thinking about competitive dynamics from some other players launching solutions this year, and what levers can you pull to stay ahead from a share perspective?”
“Olivia, thank you for sharing all the details. Investors would like tangible KPIs to track progress towards the 5% growth of the market that you mentioned today.”
“On growth margin was a bit weaker than expected in the quarter.”
Affiliation history
-
Guggenheim Securities
Analyst
Transcript header (unverified)
Current
Company network
Repligen Corp
RGEN
Medical Instruments & Supplies · Healthcare
1 appearance
Latest appearance 2025-07-29
View calls and events